A. Goussous, I. Habaibeh, K. Qaqa, N. Sunna, F. Haddad

more unusual. Therefore CGD should be considered
in the differential diagnosis of chest wall mass and
failure to do so can lead to a delay in diagnosis and
prolongs morbidity. The patient is being followed up.
She is thriving well, with no major
immunodeficiency symptoms and is tolerating
treatment well. Her most recent follow up date was
on June 2004.
Acknowledgement
We would like to thank Dr. Adel Al-Wahadneh,
pediatric immunologist, for his help and support.
References
1. Behrman RE, Kliegman RM, Jenson HB.
Leukopenia. In: Behrman RE, Kliegman RM,
Jenson HB (eds). Nelson Textbook of Pediatrics,
17 th ed. Philadelphia, WB Saunders. 2004; 121:
715-717.
2. Watane A, Jain A, Milligan T. Pediatrics in
review. Am Acad Pediatr 2000; 21(6): 205-208.
3. Segal BH, Holland SM. Primary phagocytic
disorders of childhood. Pediatr Clin North Am
2000; 47(6):1311-1312.
4. Abramson JS, Halsey NA. Red Book report of
the committee on infectious diseases. Am Acad
Pediatr 2003, 208-210.
5. Soubani AO, Chandrasekar PH. The
Clinical Spectrum of Pulmonary Aspergillosis.
Chest 2002; 121(6):1988-1999.
6. Marr KA, Balajee SA, McLaughlin L. Detection
of galactomannan antigenemia by enzyme
immunoassay for the diagnosis of invasive
aspergillosis: variables that affect performance. J
Infect Dis 2004; 190(3): 641-649.
7. Marr KA, Patterson T, Denning D.
Aspergillosis: Pathogenesis, clinical
manifestations, and therapy. Infect Dis Clin North
Am 2002; 16(4): 875-894.
8. Stevens DA, Kan VL, Judson MA, et al. Practice
Guidelines for Diseases Caused by Aspergillus.
Clin Infect Dis 2000; 30(4): 669-709.
9. Baquero-Artiago F, Garcia-Miguel MJ,
Hernandez F, et al. Combined systemic and
intrapleural treatment of Aspergillus pulmonary
empyema after invasive aspergillosis. J Pediatr
Infect Dis 2003; 22(5): 471-473.
10. Gallin J1, Alling Dw, Malech HL. Itraconazole
to prevent fungal infection in chronic
granulomatous disease. N Engl J Med 2003;
348(24): 2416-2422.
11. Bonillia FA, Geha RS. Primary
Immunodeficiency diseases. J Allergy Clin Imm
2003; 111(2): 267-268.
60
JOURNAL OF THE ROYAL MEDICAL SERVICES
Vol. 14 No. 3 December 2007